U.S. Healthcare Services Stock News

In recent months, Rush Street Interactive has reported solid quarterly results with improving operating margins and a stronger earnings outlook than many gaming peers. At the same time, concerns remain about its relatively weak revenue growth versus sector norms and the sustainability of its profitability improvements. We’ll now explore how this mix of better margins and cautious revenue expectations could reshape Rush Street Interactive’s investment narrative. Outshine the giants: these...

If you are wondering whether Citigroup stock still offers value at recent prices, it helps to step back and look at what the current share price is really implying. Citigroup closed at US$124.68, with the share price down 0.4% over the last week and 3.0% over the last month, while still up 5.0% year to date, 68.8% over the last year and 86.2% over five years. This naturally raises questions about how much of the story is already reflected in the price. Recent coverage has focused on...

Utz Brands stock performance snapshot Utz Brands (UTZ) stock closed at US$7.50, with returns down 6.4% over the past month and down 19.3% over the past 3 months, leaving the company valued at about US$1.07b. See our latest analysis for Utz Brands. The recent 1-day share price gain of 0.67% sits against a weaker backdrop, with the 1-year total shareholder return down 41.41% and the 5-year total shareholder return down 66.42%, suggesting momentum has been fading rather than building. If this...

If you are wondering whether Onto Innovation stock still offers value at recent prices, a good starting point is understanding how its current market price lines up against a range of valuation methods. The stock last closed at US$258.81, with the share price down 1.0% over the past week and 8.4% over the past month, while still showing a 56.0% year to date return and 172.3% return over the past year. Those moves sit against a backdrop of ongoing interest in semiconductor related companies,...

Why Janus Living Is Drawing Investor Attention Janus Living (JAN) is back on investor radars after fresh performance data highlighted its focus on senior housing, with recent share moves and fundamentals prompting closer scrutiny of this specialized REIT. See our latest analysis for Janus Living. At a share price of $27.54, JAN has seen a 1-month share price return of 9.03% and a year to date share price return of 16.69%, suggesting building momentum after a series of smaller recent moves. If...

After posting its latest Q1 2027 results, Burlington Stores (BURL) reported total revenue of US$2.9 billion and basic EPS of US$1.79, with trailing 12 month EPS of US$9.90 and net income of US$624.1 million framing the broader earnings picture. Over the past year, total revenue on a trailing basis moved from US$11.6 billion in Q4 2026 to US$11.9 billion in Q1 2027, while trailing EPS stepped up from US$9.69 to US$9.90 over the same period, giving investors a clear view of how the top and...

Corcept Therapeutics (CORT) has put relacorilant for Cushing’s syndrome back in front of the FDA, planning to resubmit its New Drug Application after additional analyses and discussions clarified a new six month review timeline. See our latest analysis for Corcept Therapeutics. The recent FDA update and a series of director stock option grants have arrived against a backdrop of strong momentum in the share price, with a 30 day share price return of 46.68% and a 90 day share price return of...

Hormel Foods (HRL) has reported fresh numbers for Q2 2026, with revenue of about US$3.0b and basic EPS of US$0.29. This gives investors a clear view of how the business is currently earning its profits. Over recent periods, revenue has moved between US$2,898.8m and US$3,185.7m per quarter, while basic EPS has ranged from US$0.31 to a loss of US$0.10. This highlights how earnings have shifted within a relatively tight revenue band. For investors, the key focus this quarter is what these...

Recent performance snapshot Ulta Beauty (ULTA) has drawn investor attention after a mixed run in the stock, with a gain of 2.5% over the past day but a decline of about 24% over the past 3 months. See our latest analysis for Ulta Beauty. At a share price of US$520.15, Ulta Beauty’s short term share price returns have been mixed, with the 1 month return down 3.34% and the 3 month return down 24.04%, even as the 1 year total shareholder return sits at 23.32%, suggesting earlier momentum has...

Earlier this month, Honeywell and the National Hockey League announced a multi-year global partnership making Honeywell the Official Building Automation and Energy Management Partner of the NHL, focused on modernizing arenas, practice facilities, and community rinks across North America with its AI-enabled building technologies. The collaboration highlights how Honeywell’s building automation and energy management platforms, such as Honeywell Forge, may become embedded in high-profile sports...

Modine Manufacturing (MOD) is back on investor radar after signing a long term capacity agreement to supply more than US$4b of Airedale data center cooling products through 2029, alongside record quarterly and annual results. See our latest analysis for Modine Manufacturing. Those headlines around record results and the multi year data center deal have gone hand in hand with strong momentum, with the share price delivering a 92.24% year to date return and a very large 5 year total shareholder...

In May 2026, Stryker launched its Pangea Plating System in Europe, expanding access to a globally co-designed trauma plating platform for treating diverse fracture patterns across upper and lower extremities. The system’s use of global anatomical data and variable-angle plating highlights how Stryker is tailoring implants to fit a wider range of patients and surgical preferences. Next, we’ll examine how this European Pangea launch, alongside recent operational challenges, may influence...

Earlier this week, Frontier Group Holdings reported a strong first-quarter revenue outlook with around 15% growth in Revenue per Available Seat Mile and outlined plans to defer some aircraft deliveries and terminate select leases to better manage capital spending and fleet use amid uncertain economic conditions. The combination of improving fuel cost pressures after easing geopolitical tensions and Frontier’s efforts to tighten capacity and capital outlays highlights how both external and...

NextEra Energy stock in focus NextEra Energy (NEE) is back on watch for investors after a recent pullback, with the stock down about 10% over the past month and roughly 7% over the past 3 months. See our latest analysis for NextEra Energy. While the recent pullback has cooled short term momentum, NextEra Energy’s year to date share price return of 7.81% and 1 year total shareholder return of 30.23% point to a stock that has rewarded patient holders, even as sentiment has turned more cautious...

In May 2026, Ford Motor reshaped its battery and financing structure by exiting the BlueOval SK joint venture, assuming a US$3.81 billion Department of Energy loan at 4.814% for its Kentucky battery plant, and regaining direct control of those assets. At the same time, Ford’s new Ford Energy unit secured a five-year framework to supply up to 20 GWh of battery storage systems to EDF Power Solutions North America, signaling a push to repurpose its battery capacity into grid-scale energy and...

Vertex Pharmaceuticals (VRTX) is back in focus after Health Canada agreed to review suzetrigine, a first in class non-opioid oral treatment for moderate to severe acute pain in adults. See our latest analysis for Vertex Pharmaceuticals. The Health Canada review news comes as Vertex shares trade at US$447.97, with a 1 day share price return of 2.46% and a 30 day share price return of 4.15%. However, the 90 day share price return is down 9.83%. Against that backdrop, the 5 year total...

In late May 2026, Goldman Sachs Group reshaped its digital asset exposure by fully exiting XRP and Solana ETFs, sharply cutting its Ethereum ETF holdings, and opening a new position in a digital asset treasury company linked to the Hyperliquid decentralized derivatives exchange. This shift, alongside the bank’s ongoing AI-focused market commentary and competitive 4% APY Marcus CDs, highlights how Goldman is repositioning around where it sees more durable value capture in financial technology...

Li Auto (NasdaqGS:LI) opened 2026 with Q1 revenue of ¥22.98b and a reported loss of ¥2.29b, or EPS of ¥2.26, setting a cautious tone around profitability. The company has seen quarterly revenue move from ¥44.27b in Q4 2024 to ¥22.98b in Q1 2026, while EPS has swung from ¥3.52 to a loss of ¥2.26, putting the focus squarely on how well costs are being managed against that revenue base. With investors already watching forecasts for earnings growth and a shift toward profitability, this quarter's...

Seanergy Maritime Holdings (NasdaqCM:SHIP) opened 2026 with Q1 revenue of US$42.9 million and basic EPS of US$0.46, setting a clear marker for how the dry bulk shipper is currently earning its freight. The company has seen quarterly revenue move from US$24.2 million and a loss of US$0.34 per share in Q1 2025 to US$42.9 million and EPS of US$0.46 in Q1 2026. Trailing 12 month EPS stands at US$1.81 on revenue of US$176.7 million, giving investors a results set where margins and profit trends...

Braze (BRZE) just posted its Q1 2027 numbers, reporting revenue of US$211.0 million and a basic EPS loss of US$0.24, with net income excluding extra items showing a loss of US$26.6 million. The company has seen quarterly revenue move from US$162.1 million in Q1 2026 through US$205.2 million in Q4 2026 to US$211.0 million in Q1 2027. Over the same stretch, basic EPS went from a loss of US$0.34 to a loss of US$0.29 and then a loss of US$0.24, which may lead investors to focus on how efficiently...

Boston Scientific (BSX) is back in focus after reporting strong pivotal trial data for its SEISMIQ 4CE coronary intravascular lithotripsy catheter, which met key safety and effectiveness goals in patients with severely calcified coronary artery disease. See our latest analysis for Boston Scientific. The strong SEISMIQ 4CE trial update comes against a weak recent trading backdrop, with the share price down 16% over 30 days and the 1-year total shareholder return down 53%, although the 5-year...

PG&E Foundation has launched the Nature Positive Innovation Grant program to fund environmental stewardship projects. The program focuses on supporting community based initiatives within PG&E's service area that aim to restore and protect natural habitats. This new grant effort adds another ESG focused element to PG&E's community engagement activities. For investors watching NYSE:PCG, this new grant program arrives as the stock trades around $16.29 and has recorded a gain of 58.4% over the...

Gorilla Technology Group (NasdaqCM:GRRR) opened 2026 with Q1 revenue of about US$28.2 million and a basic EPS loss of US$1.42, alongside a net income loss of roughly US$37.0 million that keeps margins under pressure. The company has seen revenue move from about US$18.3 million in Q1 2025 and US$33.9 million in Q4 2024 to the latest US$28.2 million figure, while quarterly basic EPS has ranged from a loss of US$0.23 in Q1 2025 to a deeper loss of US$4.46 in Q4 2024 before landing at a loss of...

Senator Bernie Moreno has disclosed a significant sale of eToro Group shares, as required under congressional stock transaction rules. The transaction involves NasdaqGS:ETOR and has been formally reported under legislative disclosure requirements. The sale draws attention to transparency standards for public officials trading in publicly listed companies. For investors tracking NasdaqGS:ETOR, the disclosure comes as eToro Group trades at a share price of $39.94. The stock is up 0.8% over...